Vir Biotechnology (VIR) Other Operating Expenses (2019 - 2025)
Historic Other Operating Expenses for Vir Biotechnology (VIR) over the last 6 years, with Q3 2025 value amounting to -$11000.0.
- Vir Biotechnology's Other Operating Expenses fell 10008.62% to -$11000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.4 million, marking a year-over-year decrease of 10769.7%. This contributed to the annual value of $35.8 million for FY2024, which is 11955.4% up from last year.
- Latest data reveals that Vir Biotechnology reported Other Operating Expenses of -$11000.0 as of Q3 2025, which was down 10008.62% from -$161000.0 recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Other Operating Expenses registered a high of $90.1 million during Q1 2022, and its lowest value of -$3.3 million during Q4 2024.
- Its 5-year average for Other Operating Expenses is $14.7 million, with a median of $5.5 million in 2023.
- In the last 5 years, Vir Biotechnology's Other Operating Expenses skyrocketed by 234064.69% in 2022 and then plummeted by 19090.91% in 2025.
- Over the past 5 years, Vir Biotechnology's Other Operating Expenses (Quarter) stood at $56.9 million in 2021, then plummeted by 89.46% to $6.0 million in 2022, then decreased by 6.29% to $5.6 million in 2023, then plummeted by 158.02% to -$3.3 million in 2024, then soared by 99.66% to -$11000.0 in 2025.
- Its last three reported values are -$11000.0 in Q3 2025, -$161000.0 for Q2 2025, and -$10000.0 during Q1 2025.